Testicular cancer: low testosterone and the metabolic syndrome

Cure rates for stage 1 testicular cancer are reaching 100%. However, long ‐term treatment‐related side effects pose their own health risks. Regular follow up and monitoring are important for early detection and timely treatment of conditions such as testosterone deficiency and metabolic syndrome.

Source: Trends in Urology and Men's Health - February 15, 2020 Category: Urology & Nephrology Authors: Mike Kirby Tags: Oncology Source Type: research